• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use.

作者信息

Lowe G D, Rumley A, Woodward M, Morrison C E, Philippou H, Lane D A, Tunstall-Pedoe H

机构信息

University Department of Medicine, Glasgow Royal Infirmary.

出版信息

Br J Haematol. 1997 Jun;97(4):775-84. doi: 10.1046/j.1365-2141.1997.1222936.x.

DOI:10.1046/j.1365-2141.1997.1222936.x
PMID:9217176
Abstract

Coagulation factor activity (fibrinogen, VII, VIII and IX), coagulation inhibitor activity (antithrombin, protein C, protein S), and coagulation activation markers (prothrombin fragment F1, 2; thrombin-antithrombin complexes) were measured in 747 men and 817 women aged 25-74 years, randomly sampled from the north Glasgow population in the Third MONICA Survey. Significant effects of age, sex, menopause and hormone use were observed and specific reference ranges are presented to illustrate these effects. Significant correlations were observed between several coagulation factors and inhibitors. Increased levels of factors VII, VIII and IX and decreased levels of protein C were associated with increased coagulation activation. In general, increases in coagulation factors with age were greater than increases in coagulation inhibitors, especially in men; this imbalance may favour increased coagulation activation and hence increased thrombotic risk with age.

摘要

相似文献

1
Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use.
Br J Haematol. 1997 Jun;97(4):775-84. doi: 10.1046/j.1365-2141.1997.1222936.x.
2
Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.凝血因子、抑制剂及激活标志物的流行病学:第三次格拉斯哥莫尼卡调查。II. 与心血管危险因素及心血管疾病患病率的关系
Br J Haematol. 1997 Jun;97(4):785-97. doi: 10.1046/j.1365-2141.1997.1232935.x.
3
Effects of hormone replacement on hemostasis in spontaneous menopause.激素替代疗法对自然绝经后止血的影响。
Menopause. 2001 Summer;8(2):135-40. doi: 10.1097/00042192-200103000-00009.
4
Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.心脏手术期间新生儿的纤维蛋白溶解、抗凝血酶III和蛋白C
J Thorac Cardiovasc Surg. 1996 Sep;112(3):665-71. doi: 10.1016/S0022-5223(96)70050-8.
5
Coagulation abnormalities following intensive plasma exchange on the cell separator. II. Effects on factors I, II, V, VII, VIII, IX, X and antithrombin III.血细胞分离机上进行强化血浆置换后的凝血异常。II. 对因子I、II、V、VII、VIII、IX、X及抗凝血酶III的影响
Br J Haematol. 1981 Aug;48(4):627-34. doi: 10.1111/j.1365-2141.1981.00627.x.
6
Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation.接受Fontan手术患者的止血和凝血因子异常评估。
J Thorac Cardiovasc Surg. 2000 Oct;120(4):778-82. doi: 10.1067/mtc.2000.108903.
7
Coagulation factors and antithrombin levels in young and elderly subjects in Pakistani population.巴基斯坦人群中青年和老年受试者的凝血因子及抗凝血酶水平
Blood Coagul Fibrinolysis. 2012 Dec;23(8):745-50. doi: 10.1097/MBC.0b013e328358e913.
8
Chromatography of human plasma on aminohexyl Sepharose: separation of factor VIII/vWf and behaviour of factors II, VII, IX and X and antithrombin III.
J Chromatogr. 1989 Jul 21;491(2):299-308. doi: 10.1016/s0378-4347(00)82848-0.
9
Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis.Fontan手术后促凝血和抗凝血因子异常:因子VIII增加可能易导致血栓形成。
J Thorac Cardiovasc Surg. 2003 Jun;125(6):1260-7. doi: 10.1016/s0022-5223(02)73605-2.
10
[Expanded blood coagulation screening--a necessity in diagnosis and therapy of thrombosis?].[扩展的凝血筛查——血栓形成诊断与治疗的必要手段?]
Vasa Suppl. 1992;35:92-3.

引用本文的文献

1
Aptamers: Design, Theory, and Applications to Diagnosis and Therapy for Diseases.适体:疾病诊断与治疗的设计、理论及应用
MedComm (2020). 2025 May 19;6(5):e70180. doi: 10.1002/mco2.70180. eCollection 2025 May.
2
Bleeding Risk in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Comprehensive Review.老年患者经皮冠状动脉介入治疗的出血风险:一项综合综述。
J Clin Med. 2025 Feb 12;14(4):1194. doi: 10.3390/jcm14041194.
3
A biomarker framework for liver aging: the Aging Biomarker Consortium consensus statement.肝脏衰老的生物标志物框架:衰老生物标志物联盟共识声明。
Life Med. 2024 Jan 30;3(1):lnae004. doi: 10.1093/lifemedi/lnae004. eCollection 2024 Feb.
4
Impact of Female Sex and Mild Cortisol Secretion on Coagulation Profile in Adrenal Incidentalomas.女性性别及轻度皮质醇分泌对肾上腺偶发瘤凝血指标的影响
J Endocr Soc. 2024 Dec 12;9(1):bvae215. doi: 10.1210/jendso/bvae215. eCollection 2024 Nov 26.
5
Under the dual effect of inflammation and pulmonary fibrosis, CTD-ILD patients possess a greater susceptibility to VTE.在炎症和肺纤维化的双重作用下,结缔组织病相关间质性肺病(CTD-ILD)患者发生静脉血栓栓塞症(VTE)的易感性更高。
Thromb J. 2024 Apr 4;22(1):34. doi: 10.1186/s12959-024-00599-3.
6
A novel factor IXa-specific enzyme-linked immunosorbent assay detects factor IXa in human plasma.一种新型的针对凝血因子IXa的酶联免疫吸附测定法可检测人血浆中的凝血因子IXa。
Res Pract Thromb Haemost. 2024 Feb 5;8(1):102338. doi: 10.1016/j.rpth.2024.102338. eCollection 2024 Jan.
7
GRSF1 antagonizes age-associated hypercoagulability via modulation of fibrinogen mRNA stability.GRSF1 通过调节纤维蛋白原 mRNA 稳定性来拮抗与年龄相关的高凝状态。
Cell Death Dis. 2023 Nov 3;14(11):717. doi: 10.1038/s41419-023-06242-9.
8
Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: Systematic review and meta-analysis.血浆凝血因子 VIII 和 IX 水平与静脉血栓栓塞风险:系统评价和荟萃分析。
Thromb Res. 2023 Sep;229:31-39. doi: 10.1016/j.thromres.2023.06.026. Epub 2023 Jun 28.
9
Factor VIII Activity in Relation to the Type of Thrombosis and Patient's Risk Factors for Thrombosis, Age, and Comorbidity.与血栓形成类型、患者血栓形成风险因素、年龄及合并症相关的凝血因子VIII活性
Eurasian J Med. 2023 Feb;55(1):9-13. doi: 10.5152/eurasianjmed.2023.22072.
10
Pathophysiological Aspects of Aging in Venous Thromboembolism: An Update.衰老在静脉血栓栓塞症中的病理生理学:更新。
Medicina (Kaunas). 2022 Aug 10;58(8):1078. doi: 10.3390/medicina58081078.